Literature DB >> 2460123

Fever and acute phase reactants in the rat.

H van Vugt1, J van Gool, N E Deutz.   

Abstract

In rats synthesis of some acute phase reactants can be induced by a combination of corticosteroids and adrenaline. During fever both hormones show high plasma levels. We studied the effect of fever induced by intra-cerebroventricular (i.c.v.) injection of PGE2 on the acute phase response. Fever was continuously recorded and 24 h after induction acute phase reactant (APR) response was measured as indicated by the rise of alpha-macrofetoprotein (alpha M FP, alpha 2 macroglobulin of the rat). Controls received 0.9% saline i.c.v. Controls did not develop fever (dTmax less than or equal to 1 degree C) nor did they show significant APR response. The maximal rise in body temperature after PGE2 (2.6 +/- 0.7 degrees C) correlated significantly with the rise in alpha M FP concentration 24 h later. Adrenalectomy prevented the APR response completely but the magnitude of the fever reaction remained the same (2.1 +/- 0.3 degrees C). alpha-Blockade gave a smaller fever response but had no effect on the APR response. In alpha- and beta-blockade, fever response was normal but no APR response was obtained. Destroying the sympathetic nerve supply to the liver with 6-OH dopamine retarded the fever response but again APR response was not impeded. In order to differentiate between the role of fever as such and the effect of PGE2 on APR synthesis, we used heat exposure to induce hyperthermia in normal rats who showed an APR response comparable with that after i.c.v. PGE2. Pretreatment with sodium salicylate before inducing hyperthermia led to a variable rise in alpha M FP. Fever as such, without tissue injury, induces an APR response. The pathway to this effect probably involves circulating corticosterone and adrenaline, possibly via a beta-receptor mediated stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460123      PMCID: PMC2013244     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  15 in total

1.  ACTION OF 2, 4, 5-TRIHYDROXYPHENYLETHYLAMINE ON THE STORAGE AND RELEASE OF NORADRENALINE.

Authors:  R LAVERTY; D F SHARMAN; M VOGT
Journal:  Br J Pharmacol Chemother       Date:  1965-04

2.  Practical procedure for estimation of corticosterone or hydrocortisone.

Authors:  R H SILBER; R D BUSCH; R OSLAPAS
Journal:  Clin Chem       Date:  1958-08       Impact factor: 8.327

3.  Blood-levels of hydrocortisone, transaminases, and cholesterol after myocardial infarction.

Authors:  R W Logan; W R Murdoch
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

4.  Independence of cardiovascular and hyperthermic effects of central prostaglandin E2.

Authors:  W E Hoffman; T J Valigura
Journal:  Brain Res       Date:  1979-09-07       Impact factor: 3.252

5.  Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats.

Authors:  J A Street; B A Hemsworth; A G Roach; M D Day
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-02

Review 6.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

7.  Fever produced by prostaglandin E1.

Authors:  W Feldberg; P N Saxena
Journal:  J Physiol       Date:  1971-09       Impact factor: 5.182

8.  Role of the central nervous system in acute-phase responses to leukocytic pyrogen.

Authors:  J B Turchik; D L Bornstein
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

Review 9.  Leukocytic pyrogen: a major mediator of the acute phase reaction.

Authors:  D L Bornstein
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

10.  Effect of sympathetic blockade on central prostaglandin E2-induced hyperthermia.

Authors:  W E Hoffman; R F Albrecht; D J Miletich
Journal:  Brain Res       Date:  1986-03-05       Impact factor: 3.252

View more
  1 in total

1.  Febrile responses induced in adrenalectomized rats by administration of interleukin-1 beta or prostaglandin E2.

Authors:  T Watanabe; T Makisumi; M Macari; N Tan; T Nakamori; S Nakamura; N Murakami
Journal:  J Physiol       Date:  1995-05-01       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.